Your browser doesn't support javascript.
loading
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer.
Horn, Leora; Whisenant, Jennifer G; Wakelee, Heather; Reckamp, Karen L; Qiao, Huan; Leal, Ticiana A; Du, Liping; Hernandez, Jennifer; Huang, Vincent; Blumenschein, George R; Waqar, Saiama N; Patel, Sandip P; Nieva, Jorge; Oxnard, Geoffrey R; Sanborn, Rachel E; Shaffer, Tristan; Garg, Kavita; Holzhausen, Allison; Harrow, Kimberly; Liang, Chris; Lim, Lee P; Li, Mark; Lovly, Christine M.
Afiliação
  • Horn L; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Electronic address: leora.horn@vumc.org.
  • Whisenant JG; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Wakelee H; Stanford Advanced Medicine Center, Palo Alto, California.
  • Reckamp KL; City of Hope Comprehensive Cancer Center, Duarte, California.
  • Qiao H; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Leal TA; University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Du L; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Hernandez J; Resolution Biosciences, Redmond, Washington.
  • Huang V; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Blumenschein GR; Department of Thoracic/Head and Neck Medical Oncology, The University of TX MD Anderson Cancer Center, Houston, Texas.
  • Waqar SN; Washington University School of Medicine, St. Louis, Missouri.
  • Patel SP; University of California at San Diego Moores Cancer Center, La Jolla, California.
  • Nieva J; University of Southern California Keck School of Medicine, Los Angeles, California.
  • Oxnard GR; Dana-Farber Cancer Institute, Boston, Massachussetts.
  • Sanborn RE; Earle A. Chiles Research Institute, Providence Cancer Center, Portland, Oregon.
  • Shaffer T; Resolution Biosciences, Redmond, Washington.
  • Garg K; Resolution Biosciences, Redmond, Washington.
  • Holzhausen A; Xcovery Holdings, Inc., Palm Beach Gardens, Florida.
  • Harrow K; Xcovery Holdings, Inc., Palm Beach Gardens, Florida.
  • Liang C; Xcovery Holdings, Inc., Palm Beach Gardens, Florida.
  • Lim LP; Resolution Biosciences, Redmond, Washington.
  • Li M; Resolution Biosciences, Redmond, Washington.
  • Lovly CM; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
J Thorac Oncol ; 14(11): 1901-1911, 2019 11.
Article em En | MEDLINE | ID: mdl-31446141
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Piridazinas / DNA Tumoral Circulante / Quinase do Linfoma Anaplásico / Neoplasias Pulmonares / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Piridazinas / DNA Tumoral Circulante / Quinase do Linfoma Anaplásico / Neoplasias Pulmonares / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article